Covid-19 vaccine
Scope
Date
~
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Tech, Media & Telecom
Samsung Electro-Mechanics to benefit as COVID-19 slams competitors
Samsung Electro-Mechanics is expected to benefit as the COVID-19 has hit its competitors in the global multi-layer ceramic capacitor (MLCC) market.T...
Aug 27, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Samsung to unload automaking business
Samsung Group is set to withdraw from the automaking business after 26 years in the industry since establishing Samsung Motors Inc. in 1995. The gro...
Aug 18, 2021 (Gmt+09:00)
language -
Energy
KOGAS cuts import costs on Qatari LNG with COVID-19 kits
Korea Gas Corp. (KOGAS) cut imports costs on liquefied natural gas (LNG) from Qatar for 20 years thanks to COVID-19 test kits.KOGAS signed on July 1...
Aug 17, 2021 (Gmt+09:00)
-
Covid-19 treatment
Brazil gives emergency use nod for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...
Aug 13, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience to kick off phase 3 vaccine trials
SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...
Aug 10, 2021 (Gmt+09:00)
language -
Earnings
Rubber gloves make Korean petrochemical firms’ Q2 profit soar
South Korea’s leading petrochemical makers report their second-quarter sales and operating profit soared, boosted by strong sales of rubber gl...
Aug 06, 2021 (Gmt+09:00)
-
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
Automobiles
Carmakers log strong profits despite chip shortage
Global carmakers such as Stellantis N.V., BMW, Ford Motor Co. and Hyundai Motor Group surprised investors with strong earnings despite the automotiv...
Aug 04, 2021 (Gmt+09:00)
language -
Airlines
Korean Air hits milestone of 10,000 cargo-only passenger flights
Korean Air Lines Co. (KAL) hit a milestone of having operated 10,000 cargo-only passenger flights as of Aug. 1, as the country’s top carrier g...
Aug 02, 2021 (Gmt+09:00)
language -
COVID-19
COVID treatment deals drive Samsung Bio’s record quarterly earnings
South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...
Jul 28, 2021 (Gmt+09:00)
-
Economy
Strong Korea Q2 growth keeps rate hike stance despite COVID-19 risks
South Korea's economy reported strong growth on healthy private consumption in the second quarter, keeping expectations of an interest rate hike lat...
Jul 27, 2021 (Gmt+09:00)
-
Wealth
COVID-19 shakes up Korea’s list of richest stock owners
The COVID-19 pandemic has shaken up the list of Korea’s richest people in terms of stocks held. Among the 20 richest share owners in Korea as ...
Jul 23, 2021 (Gmt+09:00)
language -
Airlines
Korean LCCs continue to face worst market conditions in 2021
Korea’s low-cost carriers (LCCs) are projected to post another period of financial loss in the second quarter of 2021.According to analyst est...
Jul 22, 2021 (Gmt+09:00)
-
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
-
IPOs
COVID-19 test kit supplier makes modest market debut
SD Biosensor Inc., the world's largest COVID-19 test kit seller, made a modest debut on the Korea Exchange on Friday, defying market expectations th...
Jul 16, 2021 (Gmt+09:00)
-
Biotech
Korea’s new PCR kits, devices to speed COVID-19 detection
South Korea’s biotechnology companies are releasing polymerase chain reaction (PCR) kits and equipment to detect COVID-19 infections within an...
Jul 15, 2021 (Gmt+09:00)
language -
COVID-19
Celltrion’s COVID-19 treatment reduces incidence of severity by 70%
Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...
Jul 13, 2021 (Gmt+09:00)
language -
IPOs
World’s top COVID-19 test kit maker draws $28 bn in IPO subscriptions
The IPO of SD Biosensor Inc., which has sold the most COVID-19 test kits in the world -- selling more than 700 million kits from February 2020 to Ma...
Jul 09, 2021 (Gmt+09:00)
-
COVID-19
COVID-19 blues? Pandemic makes SD Biosensor Korea’s top-grossing bio firm
Multinational biopharmaceutical companies have dominated the world’s diagnostics market for years. However, the coronavirus pandemic, which st...
Jul 01, 2021 (Gmt+09:00)
-
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
Biotech
Seegene develops one-stop COVID-19 testing lab on wheels; eyes MENA expansion
South Korea-based diagnostic kit maker Seegene Inc. has developed a mobile diagnostic and testing lab that offers a one-stop solution for COVID-19 t...
Jun 25, 2021 (Gmt+09:00)
-
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Pension funds
Govt pension fund to ease due diligence to revive global deals
South Korea's Government Employees Pension Service (GEPS) has abandoned its onsite only due diligence requirements on alternative deals in an effort...
Jun 14, 2021 (Gmt+09:00)
-
Central bank
Bank of Korea governor sends stronger signal to raise rates this year
South Korea’s central bank governor on Friday flagged a tighter monetary policy for the second time in less than a month, fueling expectations...
Jun 11, 2021 (Gmt+09:00)
-
Korean chipmakers
Chip shortage hits Korea’s COVID-19 diagnostic device manufacturers
The global chip shortage is impacting South Korea’s COVID-19 test device makers. They are paying up to 10 times the normal price of semiconduc...
Jun 07, 2021 (Gmt+09:00)
-
Korean stock market
Samsung returns as foreigners’ top pick; Kospi just shy of record high
Samsung Electronics Co., the bellwether of South Korea’s main bourse, has returned as the market darling, with foreigners buying heavily on th...
Jun 03, 2021 (Gmt+09:00)
language -
Alternative investments
Hana buys Osaka logistics center for about $140 mn
South Korea's Hana Alternative Asset Management Co. has beat 16 Japanese bidders to acquire a logistics center in the port of Osaka, Japan for ¥...
May 28, 2021 (Gmt+09:00)
language
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs